AUTOLIV INC
For the period ended Sep 30, 2024. Filed Oct 18, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Oct 18, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Product-Related Liabilities
- PRODUCT-RELATED LIABILITIES
The Company is exposed to product liability and warranty claims in the event that the Company’s products fail to perform as represented and such failure results, or is alleged to result, in bodily injury, and/or property damage or other loss. The Company has reserves for product risks. Such reserves are related to product performance issues, including recalls, product liability, and warranty issues. For further explanation, see Note 9. Contingent Liabilities below.
For the three months period ended September 30, 2024, cash payments mainly related to warranty- and recall-related issues. For the nine months period ended September 30, 2024, provision reversals and cash payments primarily related to recall-related issues. For the three and nine months periods ended September 30, 2023, provisions primarily related to warranty-related issues and cash payments mainly related to the Andrews litigation settlement. As of September 30, 2024, the reserve for product-related liabilities mainly consisted of recall-related issues.
The table below summarizes the change in the balance sheet position of the product-related liabilities (dollars in millions). The reserve for product-related liabilities is included in accrued expenses and other non-current liabilities on the Condensed Consolidated Balance Sheets. A majority of the Company’s product-related liabilities as of September 30, 2024 are covered by insurance. Insurance receivables are included within other current assets and other non-current assets on the Condensed Consolidated Balance Sheets. As of September 30, 2024, the Company had total insurance receivables of$58 million.
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| Reserve at beginning of the period | $73 | $178 | $96 | $145 |
| Change in reserve | 6 | 3 | (2) | 46 |
| Cash payments | (3) | (61) | (17) | (71) |
| Translation difference | 1 | (0) | 0 | (1) |
| Reserve at end of the period | $77 | $120 | $77 | $120 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.